These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 24164660)
1. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660 [TBL] [Abstract][Full Text] [Related]
2. Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus. Zhang Y; Zhang Y; Kang Y; Wang J; Liu H; Zhu H; Qin Y; Mao R; Lin X; Lu M; Zhang J J Virol Methods; 2014 Jun; 201():51-6. PubMed ID: 24583110 [TBL] [Abstract][Full Text] [Related]
3. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production. Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505 [TBL] [Abstract][Full Text] [Related]
4. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro. Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus. Pang YJ; Tan XJ; Li DM; Zheng ZH; Lei RX; Peng XM Liver Int; 2013 Sep; 33(8):1230-8. PubMed ID: 23617302 [TBL] [Abstract][Full Text] [Related]
7. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes. Kan Q; Li D; Yu Z J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir. Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991 [TBL] [Abstract][Full Text] [Related]
10. Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen. Li B; Wang Y; Shen F; Wu M; Li Y; Fang Z; Ye J; Wang L; Gao L; Yuan Z; Chen J Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224536 [TBL] [Abstract][Full Text] [Related]
11. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication. Hu Z; Hu J; Ren F; Xu H; Tan M; Wang Q; Ren J Biochem Biophys Res Commun; 2020 Mar; 523(3):802-808. PubMed ID: 31954513 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line. Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374 [TBL] [Abstract][Full Text] [Related]
13. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline]. Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125 [TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi. Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386 [TBL] [Abstract][Full Text] [Related]
15. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Shin MS; Kang EH; Lee YI Antiviral Res; 2005 Sep; 67(3):163-8. PubMed ID: 16118024 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines. Cheng Z; Sun G; Guo W; Huang Y; Sun W; Zhao F; Hu K Virol Sin; 2015 Aug; 30(4):261-8. PubMed ID: 26268473 [TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis. Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706 [TBL] [Abstract][Full Text] [Related]
18. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506 [TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970 [TBL] [Abstract][Full Text] [Related]
20. [Study of inhibition effect of bovine lactoferrin in vitro on hepatitis B surface antigen]. Li S; Huang G; Zhou H; Liu N Wei Sheng Yan Jiu; 2008 Mar; 37(2):196-8. PubMed ID: 18589607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]